SUCCESSFUL USE OF AN HMG-CoA REDUCTASE INHIBITOR AS ADJUNCTIVE THERAPY IN THE MANAGEMENT OF REFRACTORY BILE LEAK COMPLICATING LAPAROSCOPIC CHOLECYSTECTOMY.

MLA

Rabine, John, and Michael P. Jones. “SUCCESSFUL USE OF AN HMG-CoA REDUCTASE INHIBITOR AS ADJUNCTIVE THERAPY IN THE MANAGEMENT OF REFRACTORY BILE LEAK COMPLICATING LAPAROSCOPIC CHOLECYSTECTOMY.” American Journal of Gastroenterology (Springer Nature), vol. 93, no. 12, Dec. 1998, pp. 2602–03. EBSCOhost, https://doi.org/10.1111/j.1572-0241.1998.00736.x.

APA

Rabine, J., & Jones, M. P. (1998). SUCCESSFUL USE OF AN HMG-CoA REDUCTASE INHIBITOR AS ADJUNCTIVE THERAPY IN THE MANAGEMENT OF REFRACTORY BILE LEAK COMPLICATING LAPAROSCOPIC CHOLECYSTECTOMY. American Journal of Gastroenterology (Springer Nature), 93(12), 2602–2603. https://doi.org/10.1111/j.1572-0241.1998.00736.x

Chicago

Rabine, John, and Michael P. Jones. 1998. “SUCCESSFUL USE OF AN HMG-CoA REDUCTASE INHIBITOR AS ADJUNCTIVE THERAPY IN THE MANAGEMENT OF REFRACTORY BILE LEAK COMPLICATING LAPAROSCOPIC CHOLECYSTECTOMY.” American Journal of Gastroenterology (Springer Nature) 93 (12): 2602–3. doi:10.1111/j.1572-0241.1998.00736.x.